
|Articles|October 26, 2020
Pharmacy Times: Week of October 26 Lineup
This week on Pharmacy Times, there are a number of important topics that will be covered and posted throughout the week.
Advertisement
This week on Pharmacy Times, there are a number of important topics that will be covered and posted throughout the week, including:
- A video interview with Daniel Flaherty, PhD, assistant professor of medicinal chemistry and molecular pharmacology at Purdue University, and Mohamed Seleem, PhD, professor in the Department of Biomedical Sciences & Pathobiology at Virginia Polytechnic Institute and State University, about a molecule developed to fight a vancomycin-resistant enterococcus, which is a superbug.
- A new episode of the Pharmacy Focus podcast with Brooke Griffin, 21st Century PharmD, about what students can learn from the coronavirus disease 2019 pandemic.
- On Wednesday, Pharmacy Times will publish a clinical review of the first FDA-approved treatment for peanut allergy—Palforzia.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
The Peptide Reclassification Everyone's Talking About: A Pharmacist's Take on What RFK Jr's Announcement Actually Means
2
ADA 2026: Earlier GLP-1 and SGLT-2 Use Recommended From Diabetes Diagnosis, Expert Says
3
Brain Inflammation May Not Drive Persistent Long COVID Symptoms, New Imaging Study Finds
4
ADA 2026: Semaglutide Add-On Reduces Glycemic Burden, Cardiometabolic Risk in Older Adults With T2D
5





































































































































